Published in Lancet on July 21, 1979
Survival in treated hypertension: follow up study after two decades. BMJ (1998) 1.64
Microalbuminuria. BMJ (1992) 1.35
Prognosis of treated hypertension 1951-1981. Br J Clin Pharmacol (1982) 0.94
Factors predictive of attendance at clinic and blood pressure control in hypertensive patients. Br Med J (Clin Res Ed) (1983) 0.86
Microalbuminuria in systemic sclerosis. Ann Rheum Dis (1992) 0.80
Fifteen year survival of patients presenting with hypertension to a hospital clinic. Postgrad Med J (1986) 0.79
A clinician looks at the future. Br J Clin Pharmacol (1982) 0.75
Implications for anaesthesia of new concepts in cardiovascular diseases: discussion paper. J R Soc Med (1983) 0.75
Proteinuria as a prognostic factor during long term hypertensive care. Drugs (1988) 0.75
Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths). Br J Pharmacol (1971) 6.11
Validation and application of verbal autopsies in a rural area of South Africa. Trop Med Int Health (2000) 5.77
Side effects of hypotensive agents evaluated by a self-administered questionnaire. Br Med J (1973) 5.65
The effects of antihypertensive therapy on the quality of life. N Engl J Med (1986) 5.32
Monitoring adverse reactions to drugs. Br Med J (1977) 4.41
Who dies from what? Determining cause of death in South Africa's rural north-east. Trop Med Int Health (1999) 3.91
Prognosis of treated hypertension. Changes in life expectancy and causes of death between 1952 and 1967. Q J Med (1970) 3.71
A symptom questionnaire for hypertensive patients. J Chronic Dis (1974) 3.51
Outbreake of Marburg virus disease in Johannesburg. Br Med J (1975) 3.51
Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. N Engl J Med (1999) 3.43
Isoprenaline resistance and the use of pressurised aerosols in asthma. Lancet (1968) 3.33
Coeliac disease and malignancy. Lancet (1983) 3.30
Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Br Med J (1970) 3.25
Clinical pharmacology and pharmacokinetics of clonidine. Clin Pharmacol Ther (1976) 3.13
Homozygous deficiency of C3 in a patient with repeated infections. Lancet (1972) 3.04
The Agincourt demographic and health study--site description, baseline findings and implications. S Afr Med J (1999) 3.00
An evaluation of automatic coding of surgical pathology reports. J Clin Pathol (1976) 2.69
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet (1980) 2.63
Effect of propranolol in mild hypertension. Lancet (1966) 2.57
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Blood concentrations in man of fluorinated hydrocarbons after inhalation of pressurised aerosols. Lancet (1970) 2.48
Prostacyclin is not a circulating hormone in man. Prostaglandins (1982) 2.46
European journals, societies, and meetings. Meetings. Br Med J (1973) 2.46
The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial. Eur J Vasc Endovasc Surg (2003) 2.45
Symptomless diverticular disease and intake of dietary fibre. Lancet (1979) 2.45
Incidence of a positive direct coombs test in patients on alpha-methyldopa. Lancet (1966) 2.44
Fine structure mapping and properties of mutations suppressing the lon mutation in Escherichia coli K-12 and B strains. Genet Res (1977) 2.43
Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin. Br Med J (1980) 2.36
Clinical medicine and research in France. Br Med J (1973) 2.32
Dissimilation of aromatic compounds by Alcaligenes eutrophus. J Bacteriol (1971) 2.30
Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet (1991) 2.27
Computer-based hypertension clinic records: a co-operative study. Br Med J (1974) 2.24
Relation of haemoglobin levels in first and second trimesters to outcome of pregnancy. Lancet (1986) 2.24
Intravenously administered isoproterenol sulfate dose-response curves in man. Arch Intern Med (1972) 2.23
Positive direct Coombs tests and antinuclear factor in patients treated with methyldopa. Lancet (1967) 2.22
Circulating catecholamines in exercise and hyperventilation induced asthma. Thorax (1981) 2.22
Confidence intervals. Lancet (1987) 2.21
Impairment of renal function with increasing blood lead concentrations in the general population. The Cadmibel Study Group. N Engl J Med (1992) 2.17
Autoradiographic analysis of regional cell wall growth of yeasts. III. Saccharomyces cerevisiae. Exp Cell Res (1966) 2.16
Randomised controlled trial of computer-held medical records in hypertensive patients. Br Med J (1976) 2.15
Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J (1976) 2.13
Reversal in mortality trends: evidence from the Agincourt field site, South Africa, 1992-1995. AIDS (1999) 2.13
Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK Cystic Fibrosis Survey Management Committee. Arch Dis Child (1997) 2.12
Low-carbohydrate diets: nutritional and physiological aspects. Obes Rev (2006) 2.09
The metabolic fate of DL(7-3H)isoprenaline in man and dog. Biochem J (1969) 2.06
Prevalence of visual impairment in people aged 75 years and older in Britain: results from the MRC trial of assessment and management of older people in the community. Br J Ophthalmol (2002) 2.03
Improved analysis of brachial artery ultrasound using a novel edge-detection software system. J Appl Physiol (1985) (2001) 2.02
Absorption and metabolism of nicotine from cigarettes. Br Med J (1975) 2.01
Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline. Lancet (1977) 2.01
Maximal intestinal absorption of digoxin, and its relation to steady state plasma concentration. Br Heart J (1975) 2.00
Lysis of yeast cell walls induced by 2-deoxyglucose at their sites of glucan synthesis. J Bacteriol (1968) 1.99
I. Ophthalmoscopic and circulatory changes in focal retinal ischaemia. Br J Ophthalmol (1966) 1.99
Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation (2000) 1.98
Pharmacokinetics of indoramin in man. Br J Clin Pharmacol (1976) 1.97
Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization. Aging (Milano) (1991) 1.93
Salt intake, cardiovascular disease and public health. Med J Aust (1997) 1.92
Clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther (1970) 1.92
Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine. Clin Pharmacol Ther (1977) 1.91
Assessment of selective beta-adrenoceptor blockade in man. Br J Pharmacol (1973) 1.85
Genetic mapping of the lexC-113 mutation. Mol Gen Genet (1977) 1.84
The sodium, potassium, and water contents of red blood cells of healthy human adults. J Clin Invest (1966) 1.82
Evidence for a direct effect of alcohol consumption on blood pressure in normotensive men. A randomized controlled trial. Hypertension (1985) 1.81
Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. Arthritis Rheum (2000) 1.81
Influence of pattern of drinking on cardiovascular disease and cardiovascular risk factors--a review. Addiction (1999) 1.81
Pathogenesis of hypertensive retinopathy. An experimental study in the monkey. Br J Ophthalmol (1975) 1.79
Area deprivation, social class, and quality of life among people aged 75 years and over in Britain. Int J Epidemiol (2005) 1.79
Rifampicin and vitamin D metabolism. Clin Pharmacol Ther (1980) 1.78
Vascular resistance in the perfused isolated rat tail. Br J Pharmacol (1970) 1.78
Clinical evaluation of indoramin, a new antihypertensive agent. Eur J Clin Pharmacol (1973) 1.78
Minoxidil in resistant hypertension. Lancet (1977) 1.77
Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr (2000) 1.77
Association between intraocular pressure and loss of visual field in chronic simple glaucoma. Br J Ophthalmol (1990) 1.76
How far should blood pressure be lowered? N Engl J Med (1992) 1.76
The drug treatment of hypertension. Practitioner (1971) 1.75
Blood-pressure-lowering effect of a vegetarian diet: controlled trial in normotensive subjects. Lancet (1983) 1.74
Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension (1999) 1.73
Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up. Lancet (1982) 1.73
The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol (1995) 1.73
The retinal blood flow in diabetes. Diabetologia (1975) 1.72
Experimental retinal branch vein occlusion. Am J Ophthalmol (1970) 1.72